Intraocular radiotherapy treatment for macular degeneration
First Claim
Patent Images
1. A method for treating macular degeneration in the human eye, comprising:
- inserting an ionizing radiation source into the vitreous chamber of the eye;
positioning the ionizing radiation source at a location within the vitreous chamber spaced from subretinal tissue associated with macular degeneration; and
exposing the subretinal tissue to radiation emitted from the ionizing radiation source.
0 Assignments
0 Petitions
Accused Products
Abstract
A surgical device for localized delivery of beta radiation in surgical procedures, particularly ophthalmic procedures. Preferred surgical devices include a cannula with a beta radiotherapy emitting material at the distal end of the cannula. The surgical device is particularly suitable for use in the treatment of treat Age Related Macular Degeneration (AMD).
-
Citations
37 Claims
-
1. A method for treating macular degeneration in the human eye, comprising:
-
inserting an ionizing radiation source into the vitreous chamber of the eye; positioning the ionizing radiation source at a location within the vitreous chamber spaced from subretinal tissue associated with macular degeneration; and exposing the subretinal tissue to radiation emitted from the ionizing radiation source. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
-
16. A method of radiotherapy for macular degeneration, comprising:
-
providing a radiation source delivery cannula having a distal end portion; introducing the distal end portion of the cannula into the vitreous chamber of the human eye; providing an ionizing radiation source at the distal end portion of the cannula; positioning the ionizing radiation source at a location spaced from subretinal tissue; and exposing the subretinal tissue to a radiation emitted from the ionizing radiation source. - View Dependent Claims (17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)
-
-
31. A method for treating macular degeneration, comprising:
-
inserting an ionizing radiation source into the vitreous chamber of the eye; positioning the ionizing radiation source at a location within the vitreous chamber about 3 mm or less from subretinal choroidal blood vessels; and exposing the choroidal blood vessels to a therapeutically effective amount of radiation emitted from the ionizing radiation source to treat neovascularization. - View Dependent Claims (32, 33, 34, 35, 36, 37)
-
Specification